Indiana § 16-42-26.5-6 Availability of individualized investigational treatment

Indiana Statutes

§ 16-42-26.5-6 — Availability of individualized investigational treatment

Indiana § 16-42-26.5-6

Title 16HEALTH

Art. 42REGULATION OF FOOD, DRUGS, AND

Ch. 26.5Individualized Investigational Treatment

This text of Indiana § 16-42-26.5-6 (Availability of individualized investigational treatment) is published on Counsel Stack Legal Research, covering Indiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ind. Code § 16-42-26.5-6 (2026).

Text

(a)A manufacturer operating within an eligible facility and in accordance with federal law may make available to an eligible patient the manufacturer's individualized investigational treatment from an eligible facility.

(b)Nothing in this chapter may be construed to require a manufacturer of an individualized investigational treatment to make the individualized investigational treatment available to an eligible patient.

(c)A manufacturer of an individualized investigational treatment may do any of the following:

(1)Provide an individualized investigational treatment to an eligible patient without receiving compensation.

(2)Require an eligible patient to pay the costs of or associated with the manufacture of the individualized investigational treatment.

(d)This chapter does not create

Free access — add to your briefcase to read the full text and ask questions with AI

(a) A manufacturer operating within an
eligible facility and in accordance with federal law may make available
to an eligible patient the manufacturer's individualized investigational
treatment from an eligible facility.
(b) Nothing in this chapter may be construed to require a
manufacturer of an individualized investigational treatment to make the
individualized investigational treatment available to an eligible patient.
(c) A manufacturer of an individualized investigational treatment
may do any of the following:
(1) Provide an individualized investigational treatment to an
eligible patient without receiving compensation.
(2) Require an eligible patient to pay the costs of or associated
with the manufacture of the individualized investigational
treatment.
(d) This chapter does not create a cause of action against a
manufacturer of an individualized investigational treatment for any
harm to an eligible patient resulting from use of an individualized
investigational treatment.